Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.
about
Sex differences in type 2 diabetes: focus on disease course and outcomesImpact of three oral antidiabetic drugs on markers of β-cell function in patients with type 2 diabetes: a meta-analysis.A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetesThird-line agent selection for patients with type 2 diabetes mellitus uncontrolled with sulfonylureas and metformin.Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone.Beneficial effects of sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, supplemented with pioglitazone on diabetic model mice.Effects of pioglitazone add-on to gliclazide and metformin on glycemic control in patients with type 2 diabetes.Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes
P2860
Q34229975-DAD5AAB2-4507-45C6-BE8B-17744382924CQ35034772-B563E3DF-C097-472C-8EB2-853FD9102626Q36536205-5BDF3FB0-8E47-49FD-A78F-122F8ED6D70BQ37117876-7A387C3E-9A35-43D5-9846-D4E999D3AB35Q37896746-1A75D00B-0AB4-4B5F-86C7-67DF43B9E306Q45951652-85ADAF71-087F-4BAF-9577-A1B5495C03CAQ51002624-9FA10539-CCA4-4BB6-A447-37EC8C303C0EQ58329628-EA964944-D429-4E45-AEB9-3610B1BA0F3E
P2860
Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Glycaemic and nonglycaemic eff ...... patients with type 2 diabetes.
@en
Glycaemic and nonglycaemic eff ...... patients with type 2 diabetes.
@nl
type
label
Glycaemic and nonglycaemic eff ...... patients with type 2 diabetes.
@en
Glycaemic and nonglycaemic eff ...... patients with type 2 diabetes.
@nl
prefLabel
Glycaemic and nonglycaemic eff ...... patients with type 2 diabetes.
@en
Glycaemic and nonglycaemic eff ...... patients with type 2 diabetes.
@nl
P2093
P2860
P1476
Glycaemic and nonglycaemic eff ...... patients with type 2 diabetes
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2006.01665.X
P407
P577
2006-08-01T00:00:00Z